Summary
Deficiency of the enzyme aspartoacylase and the accumulation ofN-acetylaspartic acid lead to a severe leukodystrophy and spongy degeneration of the brain, Canavan disease (McKusick 271900). Since our discovery in 1988 of the defect in Canavan disease, 144 patients with Canavan disease have been diagnosed in our laboratory. Most of these children are of Ashkenazi Jewish extraction. The level of enzyme activity can be used for carrier testing. Prenatal diagnosis has been difficult using the enzyme assay owing to the low activity of aspartoacylase in cultured chorionic villus samples or amniocytes. The determination ofN-acetylaspartic acid in the amniotic fluid is another parameter for diagnosis; however, the levels may not always be elevated.
Bovine and human aspartoacylase have been purified in our laboratory. Bovine and human cDNA and genomic clones have been isolated and six exons have been localized. This information is being used for the study of Canavan disease at the molecular level.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adachi M, Torii J, Schneck L, Volk BW (1972) Electron microscopic and enzyme histochemical studies of the cerebellum in spongy degeneration (van Bogaert and Bertrand type).Acta Neuropathol 20: 22–31.
Adachi M, Schneck L, Cazara J, Volk BW (1973) Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan's Disease).Hum Pathol 4: 331–346.
Adornato BT, O'Brien JS, Lampert PW, Roe TF, Neustein HB (1972) Cerebral spongy degeneration of infancy: a biochemical and ultrastructural study of affected twins.Neurology 22: 202–210.
Banker BQ, Victor H (1979) Spongy degeneration of infancy. In Goodman R, Motulsky A, eds.Genetic Diseases Among Ashkenazi Jews. New York: Raven Press, 201–217.
Banker BQ, Robertson JJ, Victor M (1964) Spongy degeneration of the central nervous system in infancy.Neurology 14: 981–1001.
Birken DL, Oldendorf WH (1989)N-Acetyl-l-aspartic acid: A literature review of a compound prominent in1H-NMR spectroscopic studies of brain.Neurosci Behav Rev 13: 23–31.
van Bogaert L, Bertrand I (1949) Sur une idiotie familiale avec degerescence sponglieuse de neuraxe (note preliminaire).Acta Neurol Belg 49: 572–587.
van Bogaert L, Bertrand I (1967)Spongy Degeneration of Brain in Infancy. Amsterdam: North Holland, 3–132.
Buchanan DS, Davis RL (1965) Spongy degeneration of the nervous system: a report of 4 cases with a review of the literature.Neurology 15: 207–222.
Canavan MM (1931) Schilder's encephalitis periaxialis diffusa.Arch Neurol Psychiatr 25: 299–308.
Divry P, Mathieu M (1989) Aspartoacylase deficiency andN-acetylasparticaciduria in patients with Canavan disease.Am J Med Genet 32: 550.
Echenne B, Divry P, Viamey-Liaud C (1989) Spongy degeneration of the neuraxis (Canavan-Van Bogaert disease) andN-acetylaspartic aciduria.Neuropediatrics 20: 179–181.
Gambetti P, Mellman WJ, Gonatas NK (1969) Familial spongy degeneration of the central nervous system (van Bogaert-Bertrand disease).Acta Neuropathol 12: 103–115.
Globus JH, Strauss I (1928) Progressive degenerative subcortical encephalopathy (Schilder's disease).Arch Neurol Psychiatr 20: 1190–1228.
Grodd W, Kragelh-Mann I, Peterson D, Treftz FK, Harzer K (1990)In vivo assessment ofN-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy.Lancet 336: 437–438.
Hagenfeldt L, Bollgren I, Venizelos N (1987)N-Acetylaspartic aciduria due to aspartoacylase deficiency — a new etiology of childhood leukodystrophy.J Inher Metab Dis 10: 135–141.
Jacobson KB (1957) Studies on the role ofN-acetylaspartic acid on mammalian brain.J Gen Physiol 43: 323–333.
Johnson AB, Kaul RK, Casanova J, Matalon R (1989) Aspartoacylase, the deficiency enzyme in spongy degeneration (Canavan disease) is a myelin-associated enzyme.J Neuropathol Exp Neurol 48: 349.
Kaul RK, Murphy SNP, Reddy AG, Steck TL, Kohler H (1983) Amino acid sequence of theN-terminal 201 residues of human erythrocyte membrane band 3.J Biol Chem 258: 7981–7990.
Kaul RK, Casanova J, Johnson A, Tang P, Matalon R (1991a) Purification, characterization and localization of aspartoacylase from bovine brain.J Neurochem 56: 129–135.
Kaul R, Michals K, Casanova J, Matalon R (1991b) The role ofN-acetylaspartic acid in brain metabolism and the pathogenesis in Canavan disease.Int Pediatr 6: 40–43.
Kvittingen EA, Guldal G, Borsting S, Skalpe IO, Stokke O, Jellum E (1986)N-Acetylaspartic aciduria in a child with a progressive cerebral atrophy.Clin Chim Acta 158: 217–227.
Matalon R, Michals K, Sebasta D, Deanching M, Gashkoff P, Casanova J (1988) Aspartoacylase deficiency andN-acetylaspartic aciduria in patients with Canavan disease.Am J Med Genet 29: 463–471.
Matalon R, Kaul RK, Casanova J et al (1989) Aspartoacylase deficiency: the enzyme defect in Canavan disease.J Inher Metab Dis 12: 329–331.
Matalon R, Michals K, Kaul R, Mafee M (1990) Spongy degeneration of the brain, Canavan disease.Int Pediatr 5: 121–124.
Matalon R, Michals K, Gashkoff P, Kaul R (1992) Prenatal diagnosis of Canavan disease.J Inher Metab Dis 15: 392–394.
McIntosh JM, Cooper JR (1965) Studies on the function ofN-acetylaspartic acid in the brain.J Neurochem 12: 825–835.
Menkes JH (1985)Textbook of Child Neurology, 3rd edn. Philadelphia: Lea & Febiger.
Michelakakis H, Giouroukos S, Divry P, Katsarou E, Rolland MO, Skardoutsow A (1991) Canavan disease: findings in four new cases.J Inher Metab Dis 14: 267–268.
Miyake M, Kakimoto Y (1981) Developmental changes ofN-acetyl-l-aspartic acid,N-acetyl-alpha-aspartylglutamic acid and beta-citryl-l-glutamic acid in different brain regions and spinal cords of rat and guinea pig.J Neurochem 37: 1064–1067.
Miyake M, Kakimoto Y, Sorimachi M (1980) A gas chromatographic method for the determination ofN-acetyl-l-aspartic acid,N-acetyl-alpha-aspartylglutamic acid and beta-citryl-l-glutamic acid and their distributions in the brain and other organs of various species of animals.J Neurochem 36: 804–810.
Moffett JR, Namboodiri MAA, Cangro CB, Neale JH (1991) Immunohistochemical localization ofN-acetylaspartate in rat brain.Neuro Report 2: 131–134.
O'Brien DP, Zachary JF (1985) Clinical features of spongy degeneration of the central nervous system in two Labrador retriever littermates.J Am Vet Med Assoc 186: 1207–1210.
Ozand PT, Gascon G, Dhalla M (1990) Aspartoacylase deficiency and Canavan disease in Saudi-Arabia.Am J Med Genet 35: 266–268.
Rushton AR, Shaywitz BA, Dumen CC, Geehr RB, Maneulidis EE (1981) Computerized tomography in the diagnosis of Canavan's disease.Ann Neurol 10: 57–60.
Sacks O, Brown WJ, Aguilar MJ (1965) Spongy degeneration of white matter. Canavan's sclerosis.Neurology 15: 165–171.
Shigematsu H, Okamura N, Shimeno H, Kishimoto Y, Kan L, Fenselau C (1983) Purification and characterization of the heat stable factors essential for conversion of lignoceric acid to cerebronic acid and glutamic acid: identification ofN-acetyl-l-aspartic acid.J Neurochem 40: 814–820.
Tallan HH, Moore S, Stein WH (1956)N-acetyl-l-aspartic acid in brain.J Biol Chem 219: 257–264.
Ungar M, Goodman RM (1983) Spongy degeneration of the brain in Israel: A retrospective study.Clin Genet 23: 23–29.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matalon, R., Kaul, R. & Michals, K. Canavan disease: Biochemical and molecular studies. J Inherit Metab Dis 16, 744–752 (1993). https://doi.org/10.1007/BF00711906
Issue Date:
DOI: https://doi.org/10.1007/BF00711906